National Health (Originator Brand) Amendment Determination 2018 (No. 4) (PB 60 of 2018) (Cth)

Case

PB 60 of 2018

National Health (Originator Brand) Amendment Determination 2018 (No. 4)

National Health Act 1953

I, LISA LA RANCE, Assistant Secretary, Pricing and PBS Policy Branch, Technology Assessment and Access Division, Department of Health, delegate of the Minister for Health, make this Determination under subsection 99ADB (6B) of the National Health Act 1953.

Dated       27 June 2018

______________________________________

LISA LA RANCE

Assistant Secretary

Pricing and PBS Policy Branch

Technology Assessment and Access Division

Department of Health

  1. Name of Determination

(1)     This Determination is the National Health (Originator Brand) Amendment Determination 2018 (No. 4).

(2)     This Determination may also be cited as PB 60 of 2018.

  1. Commencement

This Determination commences on 1 July 2018.

  1. Amendments to PB 100 of 2015

Schedule 1 amends the National Health (Originator Brand) Determination 2015 (PB 100 of 2015).

Schedule 1     Amendments

(section 3)

[1]                  Schedule 1 (after table item 3)

omit:

3A Adrenaline

EpiPen

EpiPen Jr.

insert:

3A Adrenaline (epinephrine)

EpiPen

EpiPen Jr.

[2]                   Schedule 1 (after table item 13)

omit:

14 Amoxycillin

Amoxil

Amoxil Forte

insert:

14 Amoxicillin

Amoxil

Amoxil Forte

[3]                   Schedule 1 (after table item 14)

omit:

15 Amoxycillin with Clavulanic Acid

Augmentin

Augmentin Duo

Augmentin Duo 400

Augmentin Duo forte

insert:

15 Amoxicillin with clavulanic acid

Augmentin

Augmentin Duo

Augmentin Duo 400

Augmentin Duo forte

[4]                   Schedule 1 (after table item 28)

omit:

28A Budesonide with eformoterol

Symbicort Rapihaler 50/3

Symbicort Rapihaler 100/3

Symbicort Rapihaler 200/6

Symbicort Turbohaler 100/6

Symbicort Turbohaler 200/6

Symbicort Turbohaler 400/12

insert:

28A Budesonide with formoterol

Symbicort Rapihaler 50/3

Symbicort Rapihaler 100/3

Symbicort Rapihaler 200/6

Symbicort Turbohaler 100/6

Symbicort Turbohaler 200/6

Symbicort Turbohaler 400/12

[5]                   Schedule 1 (table item 39)

Repeal the items:

39 Cefaclor

Ceclor

Ceclor CD

39A Cefuroxime Zinnat

Substitute:

39 Cefaclor

Ceclor

Ceclor CD

39A Cefalexin Keflex
39B Cefuroxime Zinnat

[6]   Schedule 1 (table item 41)

Repeal the items:

41 Cephalexin Keflex
41A Certolizumab pegol Cimzia
41B Chorionic gonadotrophin Pregnyl

Substitute:

41 Certolizumab pegol Cimzia
41A Chorionic gonadotrophin Pregnyl
41B Ciclosporin

Neoral 25

Neoral 50

Neoral 100

[7]                   Schedule 1 (after table item 45)

omit:

46 Clomiphene Clomid

insert:

46 Clomifene Clomid

[8]                   Schedule 1 (after table item 53)

omit:

54 Cyclosporin

Neoral 25

Neoral 50

Neoral 100

[9]                   Schedule 1 (table item 78)

Repeal the items:

78 Esomeprazole Nexium
78A Esomeprazole and Clarithromycin and Amoxycillin Nexium Hp7
78B Etanercept Enbrel

substitute:

78 Esomeprazole Nexium
78A Esomeprazole and clarithromycin and amoxicillin Nexium Hp7
78B Estradiol Progynova
78C Etanercept Enbrel

[10]                 Schedule 1 (after table item 93)

omit:

94 Frusemide

Lasix

Lasix-M

insert:

94 Furosemide

Lasix

Lasix-M

[11]                 Schedule 1 (after table item 113)

omit:

114 Indomethacin Indocid

insert:

114 Indometacin Indocid

[12]                   Schedule 1 (table item 135)

Repeal the items:

135 Levonorgestrel with Ethinyestradiol Microgynon 50 ED Oral Pack containing 21 tablets 125 micrograms‑50 micrograms and 7 inert tablets
Microgynon 30 ED
Nordette 28
Oral Pack containing 21 tablets 150 micrograms‑30 micrograms and 7 inert tablets

Triphasil 28

Triquilar ED

Oral Pack containing 6 tablets 50 micrograms‑30 micrograms, 5 tablets 75 micrograms‑40 micrograms, 10 tablets 125 micrograms‑30 micrograms and 7 inert tablets
135A Lincomycin Lincocin

Substitute:

135 Levonorgestrel with ethinyestradiol Microgynon 50 ED Oral Pack containing 21 tablets 125 micrograms‑50 micrograms and 7 inert tablets
Microgynon 30 ED
Nordette 28
Oral Pack containing 21 tablets 150 micrograms‑30 micrograms and 7 inert tablets

Triphasil 28

Triquilar ED

Oral Pack containing 6 tablets 50 micrograms‑30 micrograms, 5 tablets 75 micrograms‑40 micrograms, 10 tablets 125 micrograms‑30 micrograms and 7 inert tablets
135A Levothyroxine Oroxine
135B Lincomycin Lincocin

[13]                 Schedule 1 (after table item 165)

omit:

166 Norethisterone with Ethinyloestradiol

Brevinor

Brevinor-1

insert:

166 Norethisterone with ethinylestradiol

Brevinor

Brevinor-1

[14]                 Schedule 1 (after table item 167)

omit:

168 Oestradiol Progynova

[15]                 Schedule 1 (after table item 211A)

omit:

212 Sorbitol with Sodium Citrate and Sodium Lauryl Sulfoacetate Microlax

insert:

212 Sorbitol with sodium citrate dihydrate and sodium lauryl sulfoacetate Microlax

[16]                 Schedule 1 (after table item 225)

omit:

226 Thyroxine Oroxine
Actions
Download as PDF Download as Word Document


Cases Citing This Decision

0

Cases Cited

0

Statutory Material Cited

0